Jessica Milia is a technologist in Biosciences and Computational Infrastructures, Smart Project and Quantum Computing sector of CRS4, NGS Core program. She graduated in Biology in 2018 at the University of Cagliari with a thesis focused on the identification and characterization of HIV-1 reverse transcriptase enxyme inhibitors. She got her master’s degree in Cellular and Molecular Biology in 2020 at the University of Cagliari. Her thesis was focused on the evaluation of immune response inhibition mediated by Zika Virus. From December 2020 to October 2021 she worked as Research Fellow in the Laboratory of Molecular Virology of Department of Life and Environmental Sciences (University of Cagliari). Her main activities were: – evaluation of Sars-CoV-2 viral proteins inhibition of innate immune system and identification of potential inhibitors; – identification of Sars-CoV-2 nsp13 enzyme inhibitors. From December 2021 to current she works in the NGS sequencing platform of CRS4. She is involved in nucleic acids libraries preparation, performing and monitoring of sequencing experiments for WGS, WES, RNA-Seq, target sequencing, 16s Metagenomics experiments, using Illumina instruments. She helps to evaluate quality and quantity of sequencing raw data and bioinformatic analysis results.<\/p>\n","protected":false},"featured_media":3900,"template":"","meta":{"_acf_changed":false},"gruppo":[124,125],"class_list":["post-10295","people","type-people","status-publish","has-post-thumbnail","hentry","gruppo-high-performance-and-quantum-computing-biosciences-and-advanced-studies","gruppo-next-generation-sequencing-core-en"],"acf":{"name":"Jessica","surname":"Milia","email":"jessica.milia@crs4.it","phone":"","user_uuid":"76660cdc-51fc-11ec-b200-506b8d36975d","personal_page":"","google_scholar_id":"","position":"Technologist","project_coordinator":"","microsoft_academic_id":"","team_members":[{"ID":12560,"post_author":"4","post_date":"2025-07-03 18:17:42","post_date_gmt":"2025-07-03 16:17:42","post_content":"H2UB is intended to be a Life Science infrastructure aimed at fostering new drug development through a network of laboratories capable of providing basic, translational and preclinical research support using cutting-edge technologies.\nGovernance of the Hub will be centralized and will provide support in regulatory, ethics and management, as well as organizational and dissemination. Expertise will be articulated in thematic platforms that will include:\n